These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37996254)

  • 1. Implementation of point-of-care HbA1C instruments into community pharmacies: Initial development of a pathway for robust community testing.
    Radley A; Beer L; Rushdi D; Close H; McBurney S; Mackenzie A; Gourlay A; Barnett A; Grant A; Greig N; Dow E; Sutherland C
    Ann Clin Biochem; 2024 Jul; 61(4):273-283. PubMed ID: 37996254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality Control of Norwegian Pharmacy HbA1c Testing: A Modest Beginning.
    Ørvim Sølvik U; Risøy AJ; Kjome RLS; Sandberg S
    J Diabetes Sci Technol; 2018 Jul; 12(4):753-761. PubMed ID: 29619895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Good correlation between the Afinion AS100 analyser and the ABX Pentra 400 analyser for the measurement of glycosylated haemoglobin and lipid levels in older adults in Durban, South Africa.
    Abbai NS; Nyirenda M; Reddy T; Ramjee G
    S Afr Med J; 2017 Dec; 108(1):50-55. PubMed ID: 29262979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes - A feasibility study.
    Risøy AJ; Kjome RLS; Sandberg S; Sølvik UØ
    PLoS One; 2018; 13(2):e0191316. PubMed ID: 29474501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study.
    Barron E; Misra S; English E; John WG; Sampson M; Bachmann MO; Barth J; Oliver N; Alberti KGMM; Bakhai C; O'Neill S; Young B; Wareham NJ; Khunti K; Jebb S; Smith J; Valabhji J
    BMJ Open Diabetes Res Care; 2020 Dec; 8(2):. PubMed ID: 33318069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HbA
    Kenealy T; Herd G; Musaad S; Wells S
    Prim Care Diabetes; 2019 Apr; 13(2):170-175. PubMed ID: 30545795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verification of point-of-care analysers for C-reactive protein, lipid studies and glycated haemoglobin.
    Li B; Kumar A; Finlay C; van Drimmelen M; Barnes E; Southby S; Florkowski C
    Pathology; 2023 Dec; 55(7):989-999. PubMed ID: 37778963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point-of-Care Testing in Community Pharmacies: Keys to Success From Pennsylvania Pharmacists.
    Steltenpohl EA; Barry BK; Coley KC; McGivney MS; Olenak JL; Berenbrok LA
    J Pharm Pract; 2018 Dec; 31(6):629-635. PubMed ID: 29034781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving pharmaceutical practice in diabetes care using point-of-care glycated haemoglobin testing in the community pharmacy.
    Santana CR; de Oliveira MGG; Camargo MS; Moreira PMB; de Castro PR; Aguiar EC; Mistro S
    Int J Pharm Pract; 2024 Feb; 32(1):46-51. PubMed ID: 37936510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point-of-care testing improves diabetes management in a primary care clinic in South Africa.
    Motta LA; Shephard MDS; Brink J; Lawson S; Rheeder P
    Prim Care Diabetes; 2017 Jun; 11(3):248-253. PubMed ID: 28161128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study.
    Alzubaidi HT; Chandir S; Hasan S; McNamara K; Cox R; Krass I
    BMJ Open; 2019 Nov; 9(11):e031246. PubMed ID: 31712336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemoglobin A1c: comparing performance of two point of care devices with laboratory analyser.
    Wan Mohd Zin RM; Ahmad Kamil ZI; Tuan Soh TR; Embong M; Wan Mohamud WN
    BMC Res Notes; 2013 Dec; 6():540. PubMed ID: 24344903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participant and GP perspectives and experiences of screening for undiagnosed type 2 diabetes in community pharmacy during the Pharmacy Diabetes Screening Trial.
    Krass I; Twigg MJ; Mitchell B; Wilson F; Mohebbi M; Trinder P; Shih STF; Carter R; Versace VL; McNamara K
    BMC Health Serv Res; 2023 Dec; 23(1):1337. PubMed ID: 38041094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-of-care testing of HbA1c and blood glucose in a remote Aboriginal Australian community.
    Martin DD; Shephard MD; Freeman H; Bulsara MK; Jones TW; Davis EA; Maguire GP
    Med J Aust; 2005 May; 182(10):524-7. PubMed ID: 15896181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of point of care testing on diabetes services along Victoria's Mallee Track: results of a community-based diabetes risk assessment and management program.
    Shephard MD; Mazzachi BC; Shephard AK; McLaughlin KJ; Denner B; Barnes G
    Rural Remote Health; 2005; 5(3):371. PubMed ID: 16026194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes risk assessments and HbA1c-measurements in community pharmacies.
    Risøy AJ; Kjome RLS; Sandberg S; Sølvik UØ
    Int J Pharm Pract; 2023 Sep; 31(5):512-519. PubMed ID: 37527496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy and Precision of a Point-of-Care HbA1c Test.
    Arnold WD; Kupfer K; Little RR; Amar M; Horowitz B; Godbole N; Hvidsten Swensen M; Li Y; San George RC
    J Diabetes Sci Technol; 2020 Sep; 14(5):883-889. PubMed ID: 30854894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Availability and analytical quality of hemoglobin A1c point-of-care testing in general practitioners' offices are associated with better glycemic control in type 2 diabetes.
    Tollånes MC; Jenum AK; Berg TJ; Løvaas KF; Cooper JG; Sandberg S
    Clin Chem Lab Med; 2020 Jul; 58(8):1349-1356. PubMed ID: 32229656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter assessment of a hemoglobin A1c point-of-care device for diagnosis of diabetes mellitus.
    Sobolesky PM; Smith BE; Saenger AK; Schulz K; Apple FS; Scott MG; Wu AHB; Little RR; Fitzgerald RL
    Clin Biochem; 2018 Nov; 61():18-22. PubMed ID: 30236830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Afinion HbA1c measurements in general practice as judged by external quality assurance data.
    Stavelin A; Flesche K; Tollaanes M; Christensen NG; Sandberg S
    Clin Chem Lab Med; 2020 Mar; 58(4):588-596. PubMed ID: 31821164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.